Evidence map›Paper›PMID 29163031›Full record

ArticleFrontiers in molecular neuroscience2017

MicroRNA-Mediated Regulation of

Keren Oved, Luba Farberov, Avial Gilam, Ifat Israel, Danielle Haguel, David Gurwitz, Noam Shomron

Open access · goldAbstract read
In one paragraph

Article in Frontiers in molecular neuroscience, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Comparison of MicroRNA Levels of 18-60-month-old Autistic Children with Those of Their Siblings and Controls.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2024
    Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. miRNAs in depression vulnerability and resilience: novel targets for preventive strategies.Journal of neural transmission (Vienna, Austria : 1996) · 2019
    Review
  10. Article
  11. Opportunities and challenges in psychopharmacology
.Dialogues in clinical neuroscience · 2019
    Review
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Keren OvedFaculty of Medicine, Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.
Luba FarberovFaculty of Medicine, Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.
Avial GilamFaculty of Medicine, Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.
Ifat IsraelFaculty of Medicine, Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.
Danielle HaguelFaculty of Medicine, Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.
David GurwitzFaculty of Medicine, Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.
Noam ShomronFaculty of Medicine, Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.
Tel Aviv University · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CHL1ITGB3miR-151a-3pmiR-221miR-222selective serotonin reuptake inhibitors

Identifiers

PMID29163031
PMCPMC5682014
OpenAlexW2765700487

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.